First Trust Nyse Arca Biotechnology Index Fund ETF Forecast

Buy or Hold candidate since May 19, 2026 Gain 11.21%

The First Trust NYSE Arca Biotechnology ETF price gained 0.420% on the last trading day (Monday, 22nd Jun 2026), rising from $228.83 to $229.79. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the ETF fluctuated 1.29% from a day low at $227.92 to a day high of $230.86. The price has risen in 6 of the last 10 days and is up by 3.16% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 33 thousand shares were bought and sold for approximately $7.51 million.

The ETF lies in the upper part of a strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $232.31 will firstly indicate a stronger rate of rising. Given the current short-term trend, the ETF is expected to rise 15.67% during the next 3 months and, with a 90% probability hold a price between $251.23 and $268.71 at the end of this 3-month period.

FBT Signals & Forecast

Mostly positive signals in the chart today. The First Trust NYSE Arca Biotechnology ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $227.60 and $217.13. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 6.94%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for First Trust NYSE Arca Biotechnology ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $204.86 and $200.65. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, First Trust NYSE Arca Biotechnology finds support just below today's level at $204.86. If this is broken, then the next support from accumulated volume will be at $200.65 and $198.57.

This ETF is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the ETF moved $2.94 (1.29%) between high and low. For the last week, the ETF has had daily average volatility of 1.35%.

Our recommended stop-loss: $218.74 (-4.81%) (This ETF has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (FBT) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect First Trust NYSE Arca Biotechnology Index Fund to open at $229.52, and during the day (based on 14 day Average True Range), to move between $227.82 and $231.76, which gives a possible trading interval of +/-$3.95 (+/-1.73%) up or down from last closing price. If First Trust NYSE Arca Biotechnology Index Fund takes out the full calculated possible swing range there will be an estimated 1.73% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $204.86, some $24.93 (10.85%) from the current price of $229.79, our system finds the risk reward attractive.

Is First Trust NYSE Arca Biotechnology Index Fund ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for First Trust NYSE Arca Biotechnology ETF to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 4.542 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $229.52 ( 0.116%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk